Page last updated: 2024-09-05

tolvaptan and torsemide

tolvaptan has been researched along with torsemide in 3 studies

Compound Research Comparison

Studies (tolvaptan)	Trials (tolvaptan)	Recent Studies (post-2010) (tolvaptan)	Studies (torsemide)	Trials (torsemide)	Recent Studies (post-2010) (torsemide)
967	172	786	420	112	119

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jiang, L; Liu, H; Ma, L; Wu, Z; Xu, L; Yuan, F; Zhai, Z; Zhang, J; Zhou, J	1
Hu, J; Jiang, L; Li, M; Wan, Q; Yuan, F; Zhang, Y; Zhou, J	1

Reviews

1 review(s) available for tolvaptan and torsemide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for tolvaptan and torsemide

Article	Year
Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC cardiovascular disorders, 2020, 10-14, Volume: 20, Issue:1 Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; China; Female; Fluid Shifts; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Tolvaptan; Torsemide; Treatment Outcome; Ultrafiltration; Urination; Weight Loss	2020

Article

Year

Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial.

BMC cardiovascular disorders, 2020, 10-14, Volume: 20, Issue:1

Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; China; Female; Fluid Shifts; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Tolvaptan; Torsemide; Treatment Outcome; Ultrafiltration; Urination; Weight Loss

2020

Other Studies

1 other study(ies) available for tolvaptan and torsemide

Article	Year
Short-Term Effects of Tolvaptan in Tricuspid Insufficiency Combined with Left Heart Valve Replacement-Caused Volume-Overload Patients: Results of a Prospective Pilot Study. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2019, Volume: 19, Issue:2 Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Diuretics; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Tolvaptan; Torsemide; Treatment Outcome; Tricuspid Valve; Tricuspid Valve Insufficiency; Water-Electrolyte Balance	2019

Article

Year

Short-Term Effects of Tolvaptan in Tricuspid Insufficiency Combined with Left Heart Valve Replacement-Caused Volume-Overload Patients: Results of a Prospective Pilot Study.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2019, Volume: 19, Issue:2

Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Diuretics; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Tolvaptan; Torsemide; Treatment Outcome; Tricuspid Valve; Tricuspid Valve Insufficiency; Water-Electrolyte Balance

2019